Finistere Ventures is a leading life science venture capital firm based in San Diego. We believe that early stage investments offer outstanding opportunities for superior fund returns. Our experienced team of professionals lend significant entrepreneurial, science and business expertise to help grow our portfolio companies and have the deep industry networks to provide a clear pathway to exit for our investors and companies alike. Our advisors include thought leaders and practitioners in the fields in which we invest, and enable us to understand the challenges of commercialization of innovative technologies.
Our current investment strategy focuses on Medical Devices and non-therapeutic biotech, including Agbiotech and the rapidly growing Renewable Fuels and “Green Energy” space.
Finistere Ventures investment focus is in the United States, but will consider technology opportunities from international markets and has access to dealflow in Australia and New Zealand through its sister fund, Finistere Partners.
Finistere Ventures has been awarded the mandate to operate a new fund, being raised under the Missouri Venture Partners program (“MVP). For more information go to Investment Funds.
We are nimble and pride ourselves on being able to respond with speed and focus to opportunities we engage on. As Entrepreneurs, we believe in the power of entrepreneurship to create great value from novel ideas. We are firm believers in the philosophy that we profit by creating high value businesses and outstanding rewards for investors and entrepreneurs alike.
| Company | Date | Round | Size | Participants |
| Sadra Medical | 5/09 | Series C | $30M | 7 |
| SOMARK Innovations | 2/09 | Unattributed | 4 | |
| Athenix | 1/06 | Series C | $13M | 6 |
